These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 18721528)

  • 1. Cardiovascular manifestations in human immunodeficiency virus-infected patients.
    Khunnawat C; Mukerji S; Havlichek D; Touma R; Abela GS
    Am J Cardiol; 2008 Sep; 102(5):635-42. PubMed ID: 18721528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease in HIV infection.
    Sánchez-Torres RJ; García-Palmieri MR
    P R Health Sci J; 2006 Sep; 25(3):249-54. PubMed ID: 17203795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and the cardiovascular system.
    Barbaro G; Klatt EC
    AIDS Rev; 2002; 4(2):93-103. PubMed ID: 12152522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical cardiac manifestations of HIV infection: a review of current literature.
    Chu WW; Sosman JM; Stein JH
    WMJ; 2002; 101(7):40-5, 39. PubMed ID: 12426919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease in patients infected with the human immunodeficiency virus.
    Velasquez EM; Glancy DL
    J La State Med Soc; 2003; 155(6):314-24. PubMed ID: 14750751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac manifestations in HIV-infected individual].
    Neumann T; Ross B; Hengge UR; Gerken G; Erbel R
    Med Klin (Munich); 2002 Nov; 97(11):659-65. PubMed ID: 12434274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
    Crook M
    Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of the involvement of the cardiovascular system in HIV infection.
    Barbarinia G; Barbaro G
    AIDS; 2003 Apr; 17 Suppl 1():S46-50. PubMed ID: 12870530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in HIV infection.
    Sudano I; Spieker LE; Noll G; Corti R; Weber R; Lüscher TF
    Am Heart J; 2006 Jun; 151(6):1147-55. PubMed ID: 16781213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of HIV cardiac disease.
    Cotter BR
    Prog Cardiovasc Dis; 2003; 45(4):319-26. PubMed ID: 12638095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidaemia and cardiovascular risk in HIV infection.
    Kulasekaram R; Peters BS; Wierzbicki AS
    Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients.
    Fisher SD; Kanda BS; Miller TL; Lipshultz SE
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):383-94. PubMed ID: 22149317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular injury, hypertension and coronary artery disease in human immunodeficiency virus infection.
    Barbaro G
    Clin Ter; 2008; 159(1):51-5. PubMed ID: 18399263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of dyslipidemia and other cardiovascular risk factors in HIV-infected patients: case-based review.
    Aberg JA
    Top HIV Med; 2006; 14(4):134-9. PubMed ID: 17114827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group.
    Dubé MP; Sprecher D; Henry WK; Aberg JA; Torriani FJ; Hodis HN; Schouten J; Levin J; Myers G; Zackin R; Nevin T; Currier JS;
    Clin Infect Dis; 2000 Nov; 31(5):1216-24. PubMed ID: 11073755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.
    Ntsekhe M; Hakim J
    Circulation; 2005 Dec; 112(23):3602-7. PubMed ID: 16330702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular disease in highly active antiretroviral therapy-treated individuals: incidence and risk factors.
    Monforte Ad; Bongiovanni M
    J Neurovirol; 2005; 11 Suppl 3():34-7. PubMed ID: 16540453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease and HIV infection: host, virus, or drugs?
    Martínez E; Larrousse M; Gatell JM
    Curr Opin Infect Dis; 2009 Feb; 22(1):28-34. PubMed ID: 19532078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.